Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
BioTelemetry Inc
BEAT | US
1.40
USD-0.13
-8.50%
BEAT | US
About BioTelemetry Inc
Sector
Healthcare
Industry
Diagnostics & Research
Earnings date
30/06/2024
As of date
05/03/2026
Close
1.40
Open
1.58
High
1.58
Low
1.39
HeartBeam Inc. a medical technology company primarily focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease inside and outside a healthcare facility setting. The company develops three-dimensional vector images of cardiac electrical activity. It is developing HeartBeam AIMIGo a credit card-sized cloud-based diagnostic software systems to address heart attack detection. The company was incorporated in 2015 and is based in Santa Clara California.
View LessBEAT | US
Risk
85.1
Sharpe
-0.24
Luna's Score
31/100
Recommendation
Sell
Luna says (BEAT | US)
What's Working
What's not Working
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Low negative Beta, possible Low Liquidity (< -0.4)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
70.3%1 month
85.1%3 months
231.2%6 months
192.1%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
6.93
Debt to equity
-
Debt to assets
-
Ent. to EBITDA
-2.99
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-
MarketCap
37.19M
MarketCap(USD)
37.19M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-113.62
Short ratio
1.74
Short perc.
0.62
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Range10D
0.45
Range1M
0.56
Range3M
3.31
Volumes: Market Activity
Rel. volume
1.57
Price X volume
1.28M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -2.99 | 12.67 | Cheaper |
| Ent. to Revenue | - | 44.00 | - |
| PE Ratio | - | 40.09 | - |
| Price to Book | 6.93 | 77.50 | Cheaper |
| Dividend Yield | - | 1.18 | - |
| Std. Deviation (3M) | 231.24 | 59.59 | Riskier |
| Debt to Equity | - | -14.36 | - |
| Debt to Assets | - | 0.34 | - |
| Market Cap | 37.19M | 13.71B | Emerging |
